Share This

Related Topics News -

     
 Title only   |   Print 
     
先聲藥業抗腫瘤新藥獲FDA授予快速通道資格

2024-04-10T  
先聲藥業回購建議資金加碼至10億人民幣

2024-03-21T  
《公司業績》先聲藥業全年純利7.15億人民幣跌23.2% 末期息派16分

2024-03-21T  
先聲藥業注射用蘇維西塔單抗新藥上市申請獲受理

2024-03-17T  
先聲藥業注射用SIM0500獲臨床試驗批准

2024-03-13T  
先聲藥業抗腫瘤新藥臨床試驗申請獲FDA批准

2024-03-10T  
先聲藥業附屬先聲再明獲第三方增資9.7億人民幣

2024-02-25T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.